{
    "Trade/Device Name(s)": [
        "HbA1C Enzymatic Assay Kit",
        "HbA1C Enzymatic Assay"
    ],
    "Submitter Information": "Diazyme Laboratories Division, General Atomics",
    "510(k) Number": "K050178",
    "Predicate Device Reference 510(k) Number(s)": [
        "K011434"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "JIS",
        "JJX"
    ],
    "Summary Letter Date": "June 1, 2005",
    "Summary Letter Received Date": "June 3, 2005",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glycated hemoglobin A1C"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay",
        "Kinetic assay",
        "Protease digestion",
        "Fructosyl valine oxidase reaction",
        "Peroxidase catalyzed reaction"
    ],
    "Methodologies": [
        "Quantitative enzymatic determination"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Calibrator",
        "Control",
        "Reagent",
        "Buffer"
    ],
    "Document Summary": "FDA 510(k) summary for Diazyme HbA1C Enzymatic Assay Kit for quantitative determination of glycated hemoglobin A1C in whole blood using enzymatic method",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of stable HbA1C (glycated hemoglobin A1C; A1C) in human whole blood samples as an indicator for long-term diabetic control",
    "fda_folder": "Hematology"
}